胰腺囊性病变EUS-FNA无需抗生素预防:随机试验
多中心随机非劣效试验比较环丙沙星与安慰剂在胰腺囊性病变EUS-FNA中的感染预防效果,共226例随机分组,205例完成21天随访。仅安慰剂组1例(0.87%)发生FNA相关感染(0.44%),两组感染率差异0.87%(95%CI -0.84%至2.59%),发热及其他不良事件无差异。
要点
- 胰腺囊性病变EUS-FNA不预防性使用抗生素不增加感染风险
- 仅安慰剂组1例发生FNA相关感染并继发急性胰腺炎和菌血症
- 两组发热及其他不良事件发生率无差异
核心结论
- 胰腺囊性病变EUS-FNA后感染风险低,不预防性使用环丙沙星与使用环丙沙星的感染发生率无显著差异。
研究设计与样本
- 多中心、随机、非劣效试验,在西班牙多个中心比较环丙沙星预防与安慰剂。
- 2014年9月至2018年6月纳入需EUS-FNA的胰腺囊性病变患者,随机分环丙沙星组(n=112)与生理盐水安慰剂组(n=114)。
- 共205例(90.7%)完成试验并随访21天,两组人口学、基线及操作特征无统计学显著差异。
主要发现
- 唯一FNA相关感染(0.44%)发生于安慰剂组1例(0.87%),该患者术后发生急性胰腺炎和菌血症。
- 感染预防在对照组为非劣效,两组比例差异0.87%(95%CI -0.84%至2.59%)。
- 发热两组各2例(1.78% vs 1.76%,P=1.00),其他不良事件无差异。
关键数值与推荐
- 主要结局为FNA相关感染,次要结局为发热发生率、操作并发症及药物相关不良事件。
- 感染预防非劣效:两组感染比例差异0.87%(95%CI -0.84%至2.59%)。
- 发热:环丙沙星组1.78% vs 安慰剂组1.76%,P=1.00。
临床怎么用
- 胰腺囊性病变行EUS-FNA时可不常规预防性使用抗生素。
- 术后仍需随访感染相关表现,尤其关注急性胰腺炎和菌血症等并发症。
局限性
- 原文摘要未报告非劣效界值及样本量估算细节。
- 完成试验205例(90.7%),失访可能影响结果解释。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND & AIMS: Guidelines recommend routine antibiotic prophylaxis for patients undergoing endoscopic ultrasonography-guided fine needle aspiration (EUS-FNA) of pancreatic cysts, but there is conflicting evidence for its necessity. We investigated whether performing the procedure without antimicrobial prophylaxis increases the incidence of infection. METHODS: We performed a multicenter, randomized, noninferiority trial to compare prophylaxis with ciprofloxacin vs placebo in patients with a pancreatic cyst requiring EUS-FNA at multiple centers in Spain. From September 2014 to June 2018, patients were randomly assigned to groups that received the prophylaxis with ciprofloxacin (n = 112) or saline solution (n = 114, placebo). We recorded patients' demographic data, lesion characteristics, and procedure data and followed patients for 21 days. A total of 205 patients completed the trial (90.7%), receiving ciprofloxacin or the control, with no statistically significant differences in demographics, baseline data, or procedure characteristics between groups. The primary outcome was FNA-related infection. Secondary outcomes were incidence of fever, procedure complications, and medication-related adverse events. RESULTS: The only case of FNA-related infection (0.44%) occurred in a patient in the placebo group (0.87%); this patient developed acute pancreatitis and bacteremia after the procedure. Prevention of infection was not inferior in the control group; the difference between proportions was 0.87% (95% confidence interval, -0.84% to 2.59%). There were no differences between groups in fever (2 patients in each group: 1.78% vs 1.76%; P = 1.00) or other adverse events. CONCLUSIONS: In a randomized trial of patients undergoing EUS-FNA for pancreatic cyst evaluation, we found the risk of infection to be low. The incidence of infections did not differ significantly with vs without ciprofloxacin prophylaxis. (ClinicalTrials.gov, Number: NCT02261896).
引用
- Colán-Hernández J, Sendino O, Loras C, et al. Antibiotic Prophylaxis Is Not Required for Endoscopic Ultrasonography-Guided Fine-Needle Aspiration of Pancreatic Cystic Lesions, Based on a Randomized Trial. Gastroenterology. 2020. PMID: 31972236. doi:10.1053/j.gastro.2020.01.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。